243 related articles for article (PubMed ID: 15105425)
1. Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK.
Sevilla A; Santos CR; Vega FM; Lazo PA
J Biol Chem; 2004 Jun; 279(26):27458-65. PubMed ID: 15105425
[TBL] [Abstract][Full Text] [Related]
2. c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK).
Sevilla A; Santos CR; Barcia R; Vega FM; Lazo PA
Oncogene; 2004 Nov; 23(55):8950-8. PubMed ID: 15378002
[TBL] [Abstract][Full Text] [Related]
3. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein.
Lopez-Borges S; Lazo PA
Oncogene; 2000 Jul; 19(32):3656-64. PubMed ID: 10951572
[TBL] [Abstract][Full Text] [Related]
4. The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair.
Hayakawa J; Depatie C; Ohmichi M; Mercola D
J Biol Chem; 2003 Jun; 278(23):20582-92. PubMed ID: 12663670
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma protein interacts with ATF2 and JNK/p38 in stimulating the transforming growth factor-beta2 promoter.
Li H; Wicks WD
Arch Biochem Biophys; 2001 Oct; 394(1):1-12. PubMed ID: 11566021
[TBL] [Abstract][Full Text] [Related]
6. c-Jun N-terminal kinase (JNK) positively regulates NFATc2 transactivation through phosphorylation within the N-terminal regulatory domain.
Ortega-Pérez I; Cano E; Were F; Villar M; Vázquez J; Redondo JM
J Biol Chem; 2005 May; 280(21):20867-78. PubMed ID: 15743762
[TBL] [Abstract][Full Text] [Related]
7. Stability of the ATF2 transcription factor is regulated by phosphorylation and dephosphorylation.
Fuchs SY; Tappin I; Ronai Z
J Biol Chem; 2000 Apr; 275(17):12560-4. PubMed ID: 10777545
[TBL] [Abstract][Full Text] [Related]
8. The kinetic mechanism of the dual phosphorylation of the ATF2 transcription factor by p38 mitogen-activated protein (MAP) kinase alpha. Implications for signal/response profiles of MAP kinase pathways.
Waas WF; Lo HH; Dalby KN
J Biol Chem; 2001 Feb; 276(8):5676-84. PubMed ID: 11069918
[TBL] [Abstract][Full Text] [Related]
9. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.
Vega FM; Sevilla A; Lazo PA
Mol Cell Biol; 2004 Dec; 24(23):10366-80. PubMed ID: 15542844
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
Adamson AL; Darr D; Holley-Guthrie E; Johnson RA; Mauser A; Swenson J; Kenney S
J Virol; 2000 Feb; 74(3):1224-33. PubMed ID: 10627532
[TBL] [Abstract][Full Text] [Related]
11. Zipper-mediated oligomerization of the mixed lineage kinase SPRK/MLK-3 is not required for its activation by the GTPase cdc 42 but Is necessary for its activation of the JNK pathway. Monomeric SPRK L410P does not catalyze the activating phosphorylation of Thr258 of murine MITOGEN-ACTIVATED protein kinase kinase 4.
Vacratsis PO; Gallo KA
J Biol Chem; 2000 Sep; 275(36):27893-900. PubMed ID: 10862766
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
[TBL] [Abstract][Full Text] [Related]
13. VRK1 phosphorylates CREB and mediates CCND1 expression.
Kang TH; Park DY; Kim W; Kim KT
J Cell Sci; 2008 Sep; 121(Pt 18):3035-41. PubMed ID: 18713830
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor ATF2 regulation by the JNK signal transduction pathway.
Gupta S; Campbell D; Dérijard B; Davis RJ
Science; 1995 Jan; 267(5196):389-93. PubMed ID: 7824938
[TBL] [Abstract][Full Text] [Related]
15. The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis.
Marinissen MJ; Chiariello M; Tanos T; Bernard O; Narumiya S; Gutkind JS
Mol Cell; 2004 Apr; 14(1):29-41. PubMed ID: 15068801
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2.
Miethe J; Schwartz C; Wottrich K; Wenning D; Klempnauer KH
Oncogene; 2001 Dec; 20(56):8116-24. PubMed ID: 11781825
[TBL] [Abstract][Full Text] [Related]
17. Induction of CHOP expression by amino acid limitation requires both ATF4 expression and ATF2 phosphorylation.
Averous J; Bruhat A; Jousse C; Carraro V; Thiel G; Fafournoux P
J Biol Chem; 2004 Feb; 279(7):5288-97. PubMed ID: 14630918
[TBL] [Abstract][Full Text] [Related]
18. ATM-dependent phosphorylation of ATF2 is required for the DNA damage response.
Bhoumik A; Takahashi S; Breitweiser W; Shiloh Y; Jones N; Ronai Z
Mol Cell; 2005 May; 18(5):577-87. PubMed ID: 15916964
[TBL] [Abstract][Full Text] [Related]
19. The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.
Duyndam MC; van Dam H; Smits PH; Verlaan M; van der Eb AJ; Zantema A
Oncogene; 1999 Apr; 18(14):2311-21. PubMed ID: 10327051
[TBL] [Abstract][Full Text] [Related]
20. Amino-terminal-derived JNK fragment alters expression and activity of c-Jun, ATF2, and p53 and increases H2O2-induced cell death.
Buschmann T; Yin Z; Bhoumik A; Ronai Z
J Biol Chem; 2000 Jun; 275(22):16590-6. PubMed ID: 10748185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
